Home Options Trading Advantage Options – Shares of Zogenix Rise Massively on Successful Phase...

0 75

Shares of Zogenix (ZGNX) rose sharply in trading on Friday due to positive results for its Phase 3 trial of its ZX008 drug. The drug was found to effectively cut seizure rates in patients with severe epilepsy. ZGNX shares were up over +170% on this news, and are likely to see further potential upside going forward. Keep an eye on the stock for further developments.

NO COMMENTS

Leave a Reply